Bupropion Hydrochloride
Product Images NDC 55045-3197

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 55045-3197). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dispensing Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Ndc 55045-3197-06 (Ndc 55045 3197 06 Watson)

Ndc 55045-3197-06 (Ndc 55045 3197 06 Watson)
This is a bulk source data for Bupropion HCI ER (SR) 150 mg tablets, distributed by Watson Pharma, Inc. in a tight/light resistant container. Each extended-release tablet contains Bupropion Hydrochloride USP 150 mg. The tablets are white to off-white, round and film-coated with WPI 839 imprint. It is recommended to take orally as directed by the physician, avoiding alcohol as it may cause dizziness. It is not advised to use this medicine with other drugs containing Bupropion HCI. The tablets are packaged in a bottle of 60 tablets with product number G3313 and UPC 55045-3197-06. The lot number is available on the label. A medicine guide is recommended to dispense along with the medicine.*
FDA Label Image

20ba0ead-figure-01 (Bupropion Hydrochloride 1)

20ba0ead-figure-01 (Bupropion Hydrochloride 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.